CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-01 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −656 | 56,017 | ||
| 2024-03-01 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +18,844 | $1.86 | $35K | 62,736 |
| 2024-03-01 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −18,844 | $21.77 | $410K | 44,892 |
| 2024-03-01 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Share Option 10b5-1 | −18,844 | 82,217 | ||
| 2024-03-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +5,645 | $8.83 | $50K | 23,233 |
| 2024-03-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +4,014 | $13.88 | $56K | 27,247 |
| 2024-03-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −9,659 | $21.45 | $207K | 17,588 |
| 2024-03-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Share Option 10b5-1 | −5,645 | 229 | ||
| 2024-03-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Share Option 10b5-1 | −4,014 | 0 | ||
| 2024-02-28 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +5,126 | $8.83 | $45K | 22,714 |
| 2024-02-28 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −5,126 | $21.79 | $112K | 17,588 |
| 2024-02-28 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Share Option 10b5-1 | −5,126 | 5,874 | ||
| 2024-02-27 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +10,156 | $1.86 | $19K | 55,048 |
| 2024-02-27 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −10,156 | $21.03 | $214K | 44,892 |
| 2024-02-27 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Share Option 10b5-1 | −10,156 | 101,061 | ||
| 2024-01-15 | Megna Michael R CHIEF ACCOUNTING OFFICER | Grant or award 10b5-1 | +583 | $12.35 | $7K | 17,588 |
| 2024-01-03 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +12,000 | $8.83 | $106K | 27,632 |
| 2024-01-03 | Ragosa Mark CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −12,000 | $20.00 | $240K | 15,632 |
| 2024-01-03 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Share Option 10b5-1 | −12,000 | 0 | ||
| 2024-01-02 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +16,670 | $13.88 | $231K | 33,675 |
Page 55 of 74 · 1,467 trades